Benzinga | Oct 21, 2021 12:12PM EDT

Morgan Stanley Maintains Overweight on Abbott Laboratories, Raises Price Target to $146

Morgan Stanley analyst Cecilia Furlong maintains Abbott Laboratories (NYSE:ABT) with a Overweight and raises the price target from $136 to $146.